The Department of Cognitive Disorders at the Mount Sinai Health System consists of a multi-disciplinary team of neurologists, psychiatrists, neurohospitalists, neuropsychologists, neuroscientists, and patient care managers. We provide comprehensive diagnoses and treatments for a wide range of cognitive disorders, including:
- Alzheimer’s disease
- Attention deficit disorder
- Dementia with Lewy bodies disease
- Early onset dementia
- Epilepsy-related cognitive dysfunction
- Fronto-temporal dementia
- Mild cognitive impairment
- Normal pressure hydrocephalus
- Parkinson’s disease-related cognitive dysfunction
- Posterior cortical atrophy
- Primary progressive aphasia
- Stroke-related cognitive dysfunction
- Traumatic brain injury
- Other neurologic disorder-related cognitive impairments (e.g., multiple sclerosis)
- Chemotherapy-related cognitive impairment (chemo-brain)
Our clinical trials program offers rapid access to emerging therapies for patients and their families who have already seen a doctor and are frustrated with the progression of their illness.
As a unit of the Friedman Brain Institute, we run a wide range of research programs to help us understand the underlying causes of cognitive and related neuropsychiatric disorders.
Our goal is to translate these insights into effective treatments to improve the lives of people suffering from cognitive disorders.